|Videos|April 27, 2023
Interview with Scorpius BioManufacturing’s Steven Lavezoli
Author(s)Scorpius BioManufacturing
Key Learning Objectives:
- Demonstrate that Scorpius has the expertise to bring large molecule drugs to the clinic
- Make the industry aware we have immediately available capacity
- Explain how Scorpius values the client-CDMO partnership
Related Content
Trending on Pharmaceutical Technology
1
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
2
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
Regulatory Developments Impacting Biologics
5